The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Alzheimer's Disease Drug Market Research Report 2024
Synopsis
Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.
The global Alzheimer's Disease Drug market was valued at US$ 3618 million in 2023 and is anticipated to reach US$ 4020.5 million by 2030, witnessing a CAGR of 1.5% during the forecast period 2024-2030.
The major players in global Alzheimer’s Disease Drug market include Allergan, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson & Johnson, Lundbeck, etc. The top 3 players hold over 60% of global shares. Europe and North America are main markets, they occupy over 70% of the global market. Memantine and Donepezil are the main types, with a share about 70%. Early to Moderate Stages is the key application, which covers over 55% shares.
This report aims to provide a comprehensive presentation of the global market for Alzheimer's Disease Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alzheimer's Disease Drug.
Report Scope
The Alzheimer's Disease Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Alzheimer's Disease Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Alzheimer's Disease Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Allergan
Eisai
Novartis
Daiichi Sankyo
Merz Pharma
Pfizer
Johnson & Johnson
Lundbeck
Segment by Type
Donepezil
Memantine
Rivastigmine
Others
Segment by Application
Early to Moderate Stages
Moderate to Severe Stages
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Alzheimer's Disease Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Alzheimer's Disease Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.
The global Alzheimer's Disease Drug market was valued at US$ 3618 million in 2023 and is anticipated to reach US$ 4020.5 million by 2030, witnessing a CAGR of 1.5% during the forecast period 2024-2030.
The major players in global Alzheimer’s Disease Drug market include Allergan, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson & Johnson, Lundbeck, etc. The top 3 players hold over 60% of global shares. Europe and North America are main markets, they occupy over 70% of the global market. Memantine and Donepezil are the main types, with a share about 70%. Early to Moderate Stages is the key application, which covers over 55% shares.
This report aims to provide a comprehensive presentation of the global market for Alzheimer's Disease Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alzheimer's Disease Drug.
Report Scope
The Alzheimer's Disease Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Alzheimer's Disease Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Alzheimer's Disease Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Allergan
Eisai
Novartis
Daiichi Sankyo
Merz Pharma
Pfizer
Johnson & Johnson
Lundbeck
Segment by Type
Donepezil
Memantine
Rivastigmine
Others
Segment by Application
Early to Moderate Stages
Moderate to Severe Stages
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Alzheimer's Disease Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Alzheimer's Disease Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Alzheimer's Disease Drug Market Overview
1.1 Product Overview and Scope of Alzheimer's Disease Drug
1.2 Alzheimer's Disease Drug Segment by Type
1.2.1 Global Alzheimer's Disease Drug Market Value Comparison by Type (2024-2030)
1.2.2 Donepezil
1.2.3 Memantine
1.2.4 Rivastigmine
1.2.5 Others
1.3 Alzheimer's Disease Drug Segment by Application
1.3.1 Global Alzheimer's Disease Drug Market Value by Application: (2024-2030)
1.3.2 Early to Moderate Stages
1.3.3 Moderate to Severe Stages
1.4 Global Alzheimer's Disease Drug Market Size Estimates and Forecasts
1.4.1 Global Alzheimer's Disease Drug Revenue 2019-2030
1.4.2 Global Alzheimer's Disease Drug Sales 2019-2030
1.4.3 Global Alzheimer's Disease Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Alzheimer's Disease Drug Market Competition by Manufacturers
2.1 Global Alzheimer's Disease Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Alzheimer's Disease Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Alzheimer's Disease Drug Average Price by Manufacturers (2019-2024)
2.4 Global Alzheimer's Disease Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Alzheimer's Disease Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Alzheimer's Disease Drug, Product Type & Application
2.7 Alzheimer's Disease Drug Market Competitive Situation and Trends
2.7.1 Alzheimer's Disease Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Alzheimer's Disease Drug Players Market Share by Revenue
2.7.3 Global Alzheimer's Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Alzheimer's Disease Drug Retrospective Market Scenario by Region
3.1 Global Alzheimer's Disease Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Alzheimer's Disease Drug Global Alzheimer's Disease Drug Sales by Region: 2019-2030
3.2.1 Global Alzheimer's Disease Drug Sales by Region: 2019-2024
3.2.2 Global Alzheimer's Disease Drug Sales by Region: 2025-2030
3.3 Global Alzheimer's Disease Drug Global Alzheimer's Disease Drug Revenue by Region: 2019-2030
3.3.1 Global Alzheimer's Disease Drug Revenue by Region: 2019-2024
3.3.2 Global Alzheimer's Disease Drug Revenue by Region: 2025-2030
3.4 North America Alzheimer's Disease Drug Market Facts & Figures by Country
3.4.1 North America Alzheimer's Disease Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Alzheimer's Disease Drug Sales by Country (2019-2030)
3.4.3 North America Alzheimer's Disease Drug Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Alzheimer's Disease Drug Market Facts & Figures by Country
3.5.1 Europe Alzheimer's Disease Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Alzheimer's Disease Drug Sales by Country (2019-2030)
3.5.3 Europe Alzheimer's Disease Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Alzheimer's Disease Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Alzheimer's Disease Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Alzheimer's Disease Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Alzheimer's Disease Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Alzheimer's Disease Drug Market Facts & Figures by Country
3.7.1 Latin America Alzheimer's Disease Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Alzheimer's Disease Drug Sales by Country (2019-2030)
3.7.3 Latin America Alzheimer's Disease Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Alzheimer's Disease Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Alzheimer's Disease Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Alzheimer's Disease Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Alzheimer's Disease Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Alzheimer's Disease Drug Sales by Type (2019-2030)
4.1.1 Global Alzheimer's Disease Drug Sales by Type (2019-2024)
4.1.2 Global Alzheimer's Disease Drug Sales by Type (2025-2030)
4.1.3 Global Alzheimer's Disease Drug Sales Market Share by Type (2019-2030)
4.2 Global Alzheimer's Disease Drug Revenue by Type (2019-2030)
4.2.1 Global Alzheimer's Disease Drug Revenue by Type (2019-2024)
4.2.2 Global Alzheimer's Disease Drug Revenue by Type (2025-2030)
4.2.3 Global Alzheimer's Disease Drug Revenue Market Share by Type (2019-2030)
4.3 Global Alzheimer's Disease Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Alzheimer's Disease Drug Sales by Application (2019-2030)
5.1.1 Global Alzheimer's Disease Drug Sales by Application (2019-2024)
5.1.2 Global Alzheimer's Disease Drug Sales by Application (2025-2030)
5.1.3 Global Alzheimer's Disease Drug Sales Market Share by Application (2019-2030)
5.2 Global Alzheimer's Disease Drug Revenue by Application (2019-2030)
5.2.1 Global Alzheimer's Disease Drug Revenue by Application (2019-2024)
5.2.2 Global Alzheimer's Disease Drug Revenue by Application (2025-2030)
5.2.3 Global Alzheimer's Disease Drug Revenue Market Share by Application (2019-2030)
5.3 Global Alzheimer's Disease Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Allergan
6.1.1 Allergan Corporation Information
6.1.2 Allergan Description and Business Overview
6.1.3 Allergan Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Allergan Alzheimer's Disease Drug Product Portfolio
6.1.5 Allergan Recent Developments/Updates
6.2 Eisai
6.2.1 Eisai Corporation Information
6.2.2 Eisai Description and Business Overview
6.2.3 Eisai Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Eisai Alzheimer's Disease Drug Product Portfolio
6.2.5 Eisai Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Novartis Alzheimer's Disease Drug Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Daiichi Sankyo
6.4.1 Daiichi Sankyo Corporation Information
6.4.2 Daiichi Sankyo Description and Business Overview
6.4.3 Daiichi Sankyo Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Daiichi Sankyo Alzheimer's Disease Drug Product Portfolio
6.4.5 Daiichi Sankyo Recent Developments/Updates
6.5 Merz Pharma
6.5.1 Merz Pharma Corporation Information
6.5.2 Merz Pharma Description and Business Overview
6.5.3 Merz Pharma Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Merz Pharma Alzheimer's Disease Drug Product Portfolio
6.5.5 Merz Pharma Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Pfizer Alzheimer's Disease Drug Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Johnson & Johnson
6.6.1 Johnson & Johnson Corporation Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Johnson & Johnson Alzheimer's Disease Drug Product Portfolio
6.7.5 Johnson & Johnson Recent Developments/Updates
6.8 Lundbeck
6.8.1 Lundbeck Corporation Information
6.8.2 Lundbeck Description and Business Overview
6.8.3 Lundbeck Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Lundbeck Alzheimer's Disease Drug Product Portfolio
6.8.5 Lundbeck Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Alzheimer's Disease Drug Industry Chain Analysis
7.2 Alzheimer's Disease Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Alzheimer's Disease Drug Production Mode & Process
7.4 Alzheimer's Disease Drug Sales and Marketing
7.4.1 Alzheimer's Disease Drug Sales Channels
7.4.2 Alzheimer's Disease Drug Distributors
7.5 Alzheimer's Disease Drug Customers
8 Alzheimer's Disease Drug Market Dynamics
8.1 Alzheimer's Disease Drug Industry Trends
8.2 Alzheimer's Disease Drug Market Drivers
8.3 Alzheimer's Disease Drug Market Challenges
8.4 Alzheimer's Disease Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
